← Evidence map

TrialDiabetes, obesity & metabolism2018

Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity.

Julie B Hjerpsted et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

119 papers cite itlatest 60 shown

2017
2018
2020
2021
2022
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 28941314